Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

IgG4-related kidney disease from the renal pelvis that mimicked urothelial carcinoma: a case report

Contributed equally
BMC Urology201515:44

https://doi.org/10.1186/s12894-015-0041-6

Received: 30 December 2014

Accepted: 20 May 2015

Published: 27 May 2015

Abstract

Background

IgG4-related kidney disease is a comprehensive term for renal lesions associated with IgG4-related disease, which mainly manifests as plasma cell-rich tubulointerstitial nephritis with increased IgG4+ plasma cells and fibrosis. IgG4-related kidney disease in the renal pelvis is rare.

Case presentation

We describe a 53-year-old Asian woman who was referred to our hospital with a space-occupying renal lesion discovered by medical examination. A physical examination and laboratory evaluation revealed no significant abnormalities. Computed tomography scans showed a soft-tissue mass with an irregular border and mild homogeneous enhancement in the right renal pelvis and calyces. A positron emission tomography/computed tomography scan revealed soft-tissue density shadows with increased radionuclide uptake. To investigate a suspected pelvic carcinoma, a right ureteronephrectomy was performed. A pathologic examination of the renal sections showed a dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells, with fibrosis beneath the urothelial epithelium of the renal pelvis. Postoperatively, the serum IgG4 level was significantly elevated. The patient was diagnosed with IgG4-related kidney disease.

Conclusion

We present a case of IgG4-related kidney disease mimicking urothelial carcinoma in the renal pelvis. When a buried and solitary hypovascular tumor is detected in the kidney, we must consider IgG4-related kidney disease as a differential diagnosis. Accordingly, elevated serum IgG4, radiologic findings, and pathologic examination may improve the diagnosis.

Keywords

IgG4-related disease IgG4-related kidney disease Renal pelvis Urothelial carcinoma

Background

IgG4-related disease (IgG4-RD) has recently been proposed and is considered to involve conditions of systemic inflammatory fibrosis, including autoimmune pancreatitis, retroperitoneal fibrosis, chronic sclerosing cholangitis, and inflammatory pseudotumor. IgG4-RD has now been reported in nearly every organ, though it was first identified in the pancreas and salivary glands [16]. This disease manifests as organ enlargement or nodular/hyperplastic lesions in various organs concurrently or metachronously as a result of marked infiltration of lymphocytes and IgG4-positive plasma cells as well as fibrosis.

IgG4-related kidney disease (IgG4-RKD) is a comprehensive term for renal lesions associated with IgG4-RD, which mainly manifests as plasma cell-rich tubulointerstitial nephritis (TIN) with increased IgG4+ plasma cells and fibrosis (IgG4-related TIN, IgG4-TIN) [6, 7]. Few data exist on the epidemiological and clinical features of large series of patients. The mean age at diagnosis of the reviewed cases is 65 years, and 73–87 % are men [8]. IgG4-RKD is common and predominantly involves the cortex of the kidney; however, we report a rare case of IgG4-RKD involving a renal pelvic lesion that mimicked urothelial carcinoma.

Case presentation

A 53-year-old woman was referred to our hospital with a space-occupying renal lesion that was discovered incidentally by an ultrasound scan. The patient’s past medical history was positive for a gastric ulcer.

A physical examination revealed no significant abnormalities. Laboratory evaluations, including urinalysis, were within normal limits, and urinary cytology was negative. Computed tomography (CT) scans showed a soft-tissue density mass with an irregular border and mild homogeneous enhancement in the right renal pelvis and calyces (Fig. 1). A positron emission tomography/CT scan revealed soft-tissue density shadows with increased radionuclide uptake, which suggested a malignant lesion.
Fig. 1

Abdominal computed tomography scans. These scans showed a soft-tissue density mass with an irregular border and mild homogeneous enhancement in the right renal pelvis and calyces

Because pelvic carcinoma was suspected, a right ureteronephrectomy was performed. Gross examination revealed only thickened mucosa of the renal pelvis but no obvious abnormalities in the renal cortex or medulla (Fig. 2). A pathologic examination of the renal sections showed numerous lymphoid follicles and prominent fibrosis beneath the urothelial epithelium of the thickened mucosa (Fig. 3a). Additionally, numerous plasma cells and scattered eosinophils were identified in the interfollicular area (Fig. 3b). The infiltrating lymphocytes and plasma cells did not show significant cytological atypia. Immunohistochemistry demonstrated that more than 40 % of the plasma cells were IgG4+ (Fig. 3c, 3d). All of these histologic changes were confined to the renal pelvis and did not involve the renal parenchyma. The postoperative serum IgG4 level was 3250 mg/L (80–1400 mg/L). The patient was diagnosed with IgG4-RKD and no specific therapy was administered. The postoperative serum IgG4 level decreased from 3250 mg/L to 2450 mg/L at 2 months.
Fig. 2

Gross examination revealed thickened mucosa of the renal pelvis

Fig. 3

Pathologic examination of the renal sections. (a). Numerous lymphoid follicles and prominent fibrosis beneath the urothelial epithelium of the renal pelvis; (b). Numerous plasma cells and scattered eosinophils were identified in the interfollicular area. Immunohistochemistry showed numerous IgG+ (c) and IgG4+ (d) plasma cells

Discussion

IgG4-RKD is a comprehensive term for renal lesions, including renal parenchymal lesions and renal pelvic lesions, related to IgG4-RD, which is a recently recognized and proposed clinical entity characterized by a dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells with fibrosis that affects several organs [6, 9]. TIN involving tubules and/or the interstitium of the kidney is the most dominant feature of IgG4-RKD [9]; however, IgG4-RKD in the renal pelvis is rare [710]. Here, we report a rare case of IgG4-RKD that mimicked renal pelvic carcinoma.

A comprehensive English and non-English search for all articles pertinent to IgG4-RD of the renal pelvis was conducted using PubMed. Since Naoto Kuroda [11] first reported a case of IgG4-RD arising in the renal pelvis in 2009, six cases of IgG4-RD of the renal pelvis have been reported previously in the world literature (Table 1) [1216]. The mean age at diagnosis was 59.8 years (range: 49 to 80 years), with a male: female ratio of 1:1. Most patients presented with renal lesions in the left kidney, with a left-to-right presentation ratio of 2:1. Patients visited the hospital with or without complaints of non-characteristic presentations (i.e., flank pain), and none of the patients had hematuria. Hypocomplementemia and elevated serum IgG are characteristic features of IgG4-RD. Elevated serum IgG and IgG4 were found in all patients, but no hypocomplementemia was found in these seven cases, including our case (Table 1). Although hypocomplementemia is a distinct feature of IgG4-RD, a relatively low proportion of patients actually have it.
Table 1

Previous reports of IgG4-related kidney disease arising in the renal pelvis

Ref.

Age (years)

Sex

Manifestations

Hypocomplementemia

Extra-renal lesions

Location

Serum IgG4

Therapy

Findings at follow-up

12

58

M

None

NA

IgG4-related MD

Left

Elevated

Surgery + corticosteroid

Dead

13

80

M

NA

NA

None

Right

NA

Surgery

NA

14

69

M

NA

NA

None

Right

Elevated

Surgery + corticosteroid

Regression of the manifestations

11

49

F

None

None

IgG4-related MD

Left

Elevated

Surgery

NA

15

49

F

Bilateral lumbago

NA

None

Left

Elevated

Corticosteroid

Regression of the manifestations

16

54

F

Left flank discomfort and palpebral edema

None

None

Left

Elevated

Corticosteroid

Regression of the manifestations

F, female; M, male; MD, mikulicz’s disease; NA, unavailable

Patients with IgG4-RD often have lesions in several organs, either synchronously or metachronously, although others may show the involvement of only a single organ. Renal lesions are recognized as extra-pancreatic manifestations of IgG4-RD; the condition can develop as IgG4-RKD singly or associated with the lesions of other organs. In previous cases, renal and extra-renal (salivary gland) involvements in IgG4-RD have presented simultaneously in two patients [11, 12]. In the current case, a systemic examination showed no other abnormal findings, inclusive of the salivary glands, lacrimal glands, and pancreas. Thus, the condition was diagnosed as IgG4-RD isolated in the renal pelvis without the involvement of other organs.

On the basis of the results of a diagnostic algorithm procedure and with references to several diagnostic criteria for AIP, Mitsuhiro Kawano [6] proposed diagnostic criteria for IgG4-RKD: (1) presence of some kidney damage, as manifested by laboratory examination; (2) kidney imaging studies showing abnormal renal findings, i.e., multiple low-density lesions on enhanced CT; (3) elevated serum IgG4 levels exceeding 135 mg/dL; (4) renal histology showing dense lymphoplasmacytic infiltration with infiltrating IgG4+ plasma cells and fibrosis; and (5) extra-renal histology showing prominent lymphoplasmacytic infiltration with infiltrating IgG4+ plasma cells. The diagnosis is classified into three stages—definite, probable, and possible—according to the combinations of the above conditions. In their diagnostic criteria, abnormal renal imaging findings were essential for making a definitive diagnosis. In the present case, all of these conditions, including imaging studies that identified low-density lesions, pathologic examinations that revealed characteristic changes, and elevated serum IgG4, prompted the definitive diagnosis of IgG4-RKD.

A rapid response to corticosteroid therapy is a characteristic feature of IgG4-RD, and corticosteroids are typically the first line of therapy, although no controlled trial has been performed. Moreover, the protocol used for corticosteroid therapy varies among countries and institutions [1]. Because of the decreased level of serum IgG4 after ureteronephrectomy, our patient received a close follow-up without corticosteroid therapy. In the reported cases, patients with IgG4-RKD arising from the renal pelvis were treated according to different strategies, including surgical treatment alone for two patients, corticosteroid therapy alone for two patients, and surgical and corticosteroid treatment for the remaining two patients. The renal lesions improved or resolved after the corticosteroid treatment in three patients who received corticosteroid treatment (Table 1). Takahashi and colleagues [17] also found that lesions progressed in three IgG4-TIN patients receiving no corticosteroid treatment or surgical resection and that lesions regressed in all IgG4-TIN patients who underwent corticosteroid treatment. These observations indicate that effective interventions should begin as soon as possible for irreversible fibrosis in IgG4-RKD. Because corticosteroid treatment has a remarkable effect in this type of disease, at least in the short term, this treatment is vital to avoid unnecessary surgery. CT-guided biopsy or laparoscopic biopsy of the original tumor might help to rule out malignancy.

Recent studies have revealed several characteristic clinical features of IgG4-RKD, including predominance in middle-aged to older men, frequent association with IgG4-RD in other organs, high levels of serum IgG and IgG4, and a good initial response to corticosteroids. However, longer follow-up data for IgG4-RKD, including relapse information, are still sparse. Takako Saeki and his colleagues [18] retrospectively analyzed the longer-term clinical course of 43 patients with IgG4-TIN in detail in a larger cohort. This analysis included the largest series on the long-term outcomes of corticosteroid treatment of IgG4-RKD. Saeki et al. showed that 1 month after the start of treatment, most of the abnormal serology and radiology parameters had improved, and relapse of IgG4-related lesions occurred in 8 of 40 treated patients. These studies indicate that the response of IgG4-RKD to corticosteroids is rapid and partial, and that irreversible lesions may remain, especially in patients with advanced renal damage. Patients with renal dysfunction should receive corticosteroid therapy, although spontaneous improvement of lesions can also occur in IgG4-TIN and the indications for corticosteroid therapy in IgG4-RKD have not been established. Careful attention should be paid to renal function during follow-up without therapy [18, 19]. A large-scale prospective study is necessary to determine a more useful treatment strategy for IgG4-RKD.

Conclusions

We present a case of IgG4-RKD that mimicked urothelial carcinoma in the renal pelvis. When a deep and solitary hypovascular tumor is detected in the kidney, we must consider IgG4-RKD as a differential diagnosis. Accordingly, elevated serum IgG4, radiologic findings, and pathologic examination may be helpful for the diagnosis.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Notes

Abbreviations

IgG-RD: 

IgG-related disease

IgG-RKD: 

IgG-related kidney disease

TIN: 

Tubulointerstitial nephritis

CT: 

Computed tomography

Declarations

Acknowledgments

The authors thank Yufeng Luo, Department of Pathology, for her technical assistance with immunohistochemistry staining. We also thank Shuo Li, Department of Radiology, for help with the preparation of the radiological materials.

Authors’ Affiliations

(1)
Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
(2)
Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

References

  1. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.View ArticlePubMedGoogle Scholar
  2. Brito-Zerón P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13(12):1203–10.View ArticlePubMedGoogle Scholar
  3. Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol. 2003;27:441–51.View ArticlePubMedGoogle Scholar
  4. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.View ArticlePubMedGoogle Scholar
  5. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20:884–94.View ArticlePubMedGoogle Scholar
  6. Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615–26.View ArticlePubMedGoogle Scholar
  7. Yamaguchi Y, Kanetsuna Y, Honda K, Yamanaka N, Kawano M, Nagata M. Japanese study group on IgG4-related nephropathy. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536–49.View ArticlePubMedGoogle Scholar
  8. Kawano M, Saeki T. IgG4-related kidney disease - an update. Curr Opin Nephrol Hypertens. 2015;24(2):193–201.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85:251–7.View ArticlePubMedGoogle Scholar
  10. Lee LY, Yap H, Sampson S, Ford B, Hayman G, Marsh J, et al. IgG4- related disease as a rare cause of tubulointerstitial nephritis. J Clin Immunol. 2014;34:548–50.View ArticlePubMedGoogle Scholar
  11. Kuroda N, Nakamura S, Miyazaki K, Inoue K, Ohara M, Mizuno K, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol. 2009;42:236–8.View ArticlePubMedGoogle Scholar
  12. Uehara T, Ikeda S, Hamano H, Kawa S, Moteki H, Matsuda K, et al. A case of Mikulicz’s disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med. 2012;51:419–23.View ArticlePubMedGoogle Scholar
  13. Takata M, Miyoshi M, Kohno M, Ito M, Komatsu K, Tsukahara K. Two cases of IgG4-related systemic disease arising from urinary tract. Hinyokika Kiyo. 2012;58:613–6.PubMedGoogle Scholar
  14. Tsuzaka Y, Ookubo K, Sugiyama K, Morimoto H, Amano H, Oota N, et al. IgG4-related kidney disease: a long-term follow up case of pseudotumor of the renal pelvis. Nihon Hinyokika Gakkai Zasshi. 2014;105:51–5.PubMedGoogle Scholar
  15. Inoue S, Takahashi C, Hikita K. A case of IgG4-related retroperitoneal fibrosis from the renal pelvis mimicking bilateral hydronephrosis. Urol Int. 2014 Apr;8.Google Scholar
  16. Yiwei W, Xing C, Rongkui L, Hang W, Guomin W, Yingyong H, et al. IgG4-related systemic disease mimicking renal pelvic cancer: a rare case. World J Surg Oncol. 2014;12:395.View ArticleGoogle Scholar
  17. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007;242(3):791–801.View ArticlePubMedGoogle Scholar
  18. Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84(4):826–33.View ArticlePubMedGoogle Scholar
  19. Kawano M, Yamada K. Treatment of IgG4-related disease. Curr Immunol Rev. 2011;7:246–51.View ArticleGoogle Scholar

Copyright

© Zhang et al.; licensee BioMed Central. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement